The mechanism of Artenimol-R improves cervical cancer is that Artenimol-R treatment results in significant reductions of p53, epidermal growth factor receptor (EGFR), Ki-67 (a marker of tumor proliferation) and angiogenesis (142). This evidence concerns the gene MKI67 and neoplasm.